Sarah Uhler Morton, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heart Defects, Congenital | 24 | 2024 | 4584 | 3.160 |
Why?
|
Dexmedetomidine | 3 | 2021 | 315 | 1.760 |
Why?
|
Intensive Care Units, Neonatal | 8 | 2023 | 780 | 1.740 |
Why?
|
Hypnotics and Sedatives | 3 | 2021 | 1162 | 1.370 |
Why?
|
Paenibacillus | 3 | 2023 | 14 | 1.350 |
Why?
|
Executive Function | 3 | 2023 | 1364 | 1.050 |
Why?
|
Lutein | 2 | 2022 | 125 | 1.020 |
Why?
|
Hydrocephalus | 4 | 2023 | 748 | 0.960 |
Why?
|
Infant, Newborn | 24 | 2023 | 25625 | 0.910 |
Why?
|
Midazolam | 2 | 2021 | 270 | 0.890 |
Why?
|
Breast Feeding | 2 | 2022 | 1338 | 0.870 |
Why?
|
Meningitis | 1 | 2023 | 216 | 0.800 |
Why?
|
Muscle Hypotonia | 1 | 2022 | 165 | 0.750 |
Why?
|
Myotonic Dystrophy | 1 | 2021 | 78 | 0.750 |
Why?
|
Erythrocyte Count | 1 | 2020 | 163 | 0.730 |
Why?
|
Intensive Care, Neonatal | 1 | 2021 | 198 | 0.720 |
Why?
|
Transcription Factor TFIID | 1 | 2020 | 151 | 0.700 |
Why?
|
Myoblasts | 1 | 2021 | 238 | 0.700 |
Why?
|
TATA-Binding Protein Associated Factors | 1 | 2020 | 104 | 0.690 |
Why?
|
Lactation | 1 | 2021 | 412 | 0.680 |
Why?
|
Infant, Premature | 4 | 2023 | 2044 | 0.660 |
Why?
|
Drug Substitution | 1 | 2021 | 281 | 0.660 |
Why?
|
Benzodiazepines | 2 | 2021 | 1101 | 0.660 |
Why?
|
Cerebrum | 1 | 2020 | 137 | 0.660 |
Why?
|
Infant, Newborn, Diseases | 2 | 2023 | 582 | 0.650 |
Why?
|
Carotenoids | 1 | 2021 | 624 | 0.650 |
Why?
|
Bronchopulmonary Dysplasia | 1 | 2022 | 306 | 0.650 |
Why?
|
MicroRNAs | 6 | 2022 | 3752 | 0.640 |
Why?
|
Induced Pluripotent Stem Cells | 4 | 2024 | 1736 | 0.640 |
Why?
|
Histone Acetyltransferases | 1 | 2020 | 336 | 0.630 |
Why?
|
Infant | 23 | 2024 | 35136 | 0.610 |
Why?
|
Apoptosis Inducing Factor | 1 | 2017 | 55 | 0.590 |
Why?
|
Mitochondrial Encephalomyopathies | 1 | 2017 | 37 | 0.590 |
Why?
|
Maternal Nutritional Physiological Phenomena | 1 | 2020 | 378 | 0.570 |
Why?
|
Tetralogy of Fallot | 1 | 2021 | 623 | 0.550 |
Why?
|
Heart | 6 | 2023 | 4467 | 0.540 |
Why?
|
Cofilin 2 | 1 | 2015 | 12 | 0.530 |
Why?
|
Bradycardia | 3 | 2021 | 307 | 0.530 |
Why?
|
Sepsis | 3 | 2023 | 2593 | 0.500 |
Why?
|
Apnea | 1 | 2016 | 195 | 0.490 |
Why?
|
Muscle, Skeletal | 3 | 2021 | 4931 | 0.490 |
Why?
|
RNA, Messenger | 5 | 2022 | 13033 | 0.480 |
Why?
|
Nutritional Status | 1 | 2021 | 1609 | 0.450 |
Why?
|
Mutation, Missense | 4 | 2021 | 2564 | 0.450 |
Why?
|
Morphine | 3 | 2021 | 657 | 0.440 |
Why?
|
Enteral Nutrition | 1 | 2018 | 763 | 0.420 |
Why?
|
Child Development | 2 | 2021 | 2223 | 0.410 |
Why?
|
Neonatology | 2 | 2023 | 122 | 0.380 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2020 | 1344 | 0.370 |
Why?
|
Respiration, Artificial | 1 | 2021 | 2569 | 0.370 |
Why?
|
Genomics | 5 | 2023 | 5720 | 0.360 |
Why?
|
Infant, Premature, Diseases | 1 | 2016 | 706 | 0.360 |
Why?
|
Quality Improvement | 2 | 2021 | 3749 | 0.350 |
Why?
|
Adaptation, Physiological | 1 | 2016 | 1312 | 0.340 |
Why?
|
Child | 22 | 2023 | 77709 | 0.330 |
Why?
|
Fetus | 1 | 2016 | 1880 | 0.330 |
Why?
|
Uganda | 5 | 2023 | 1243 | 0.310 |
Why?
|
Cardiomyopathy, Dilated | 3 | 2018 | 851 | 0.300 |
Why?
|
Humans | 60 | 2024 | 744343 | 0.290 |
Why?
|
Pregnancy | 9 | 2023 | 29144 | 0.290 |
Why?
|
Cell Cycle | 1 | 2015 | 2967 | 0.280 |
Why?
|
Hospital Mortality | 1 | 2020 | 5317 | 0.280 |
Why?
|
Regeneration | 1 | 2015 | 1485 | 0.270 |
Why?
|
Genetic Predisposition to Disease | 5 | 2021 | 17446 | 0.260 |
Why?
|
Genetic Testing | 5 | 2023 | 3444 | 0.260 |
Why?
|
Length of Stay | 1 | 2018 | 6309 | 0.250 |
Why?
|
DNA, Mitochondrial | 2 | 2022 | 817 | 0.250 |
Why?
|
Body Patterning | 1 | 2008 | 626 | 0.240 |
Why?
|
Embryonic Development | 1 | 2008 | 711 | 0.230 |
Why?
|
Diet | 1 | 2021 | 7939 | 0.230 |
Why?
|
Drug Administration Schedule | 2 | 2021 | 4933 | 0.230 |
Why?
|
Diabetes Mellitus | 1 | 2022 | 5751 | 0.220 |
Why?
|
Gestational Age | 2 | 2022 | 3493 | 0.220 |
Why?
|
Tooth Abnormalities | 1 | 2023 | 54 | 0.220 |
Why?
|
Female | 29 | 2023 | 380194 | 0.220 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15540 | 0.210 |
Why?
|
Bone Diseases, Developmental | 1 | 2023 | 130 | 0.210 |
Why?
|
Photometry | 1 | 2021 | 58 | 0.210 |
Why?
|
alpha-Tocopherol | 1 | 2022 | 127 | 0.200 |
Why?
|
Case-Control Studies | 5 | 2023 | 21746 | 0.200 |
Why?
|
Zebrafish | 3 | 2017 | 2994 | 0.200 |
Why?
|
Muscular Diseases | 2 | 2017 | 556 | 0.200 |
Why?
|
GATA4 Transcription Factor | 1 | 2022 | 131 | 0.190 |
Why?
|
Adolescent | 13 | 2023 | 85781 | 0.190 |
Why?
|
Hospitals, Pediatric | 2 | 2021 | 1775 | 0.190 |
Why?
|
Practice Guidelines as Topic | 1 | 2018 | 7279 | 0.190 |
Why?
|
Neural Tube Defects | 1 | 2023 | 256 | 0.190 |
Why?
|
GATA6 Transcription Factor | 1 | 2020 | 50 | 0.190 |
Why?
|
Genes, X-Linked | 1 | 2021 | 128 | 0.190 |
Why?
|
Rhabdoid Tumor | 1 | 2022 | 212 | 0.180 |
Why?
|
Hypoxia-Ischemia, Brain | 1 | 2023 | 333 | 0.180 |
Why?
|
Oxidoreductases | 1 | 2022 | 424 | 0.170 |
Why?
|
Paternal Age | 1 | 2019 | 84 | 0.170 |
Why?
|
Monosomy | 1 | 2019 | 54 | 0.170 |
Why?
|
Genes, Neoplasm | 1 | 2021 | 376 | 0.170 |
Why?
|
Motor Skills | 1 | 2022 | 522 | 0.170 |
Why?
|
Virulence Factors | 1 | 2022 | 509 | 0.170 |
Why?
|
Diaphragm | 1 | 2020 | 349 | 0.170 |
Why?
|
DNA Copy Number Variations | 3 | 2023 | 1941 | 0.160 |
Why?
|
Growth Differentiation Factor 1 | 1 | 2017 | 6 | 0.160 |
Why?
|
Sarcomeres | 1 | 2021 | 374 | 0.160 |
Why?
|
Hypothermia, Induced | 1 | 2023 | 752 | 0.160 |
Why?
|
Peptide Elongation Factor 1 | 1 | 2017 | 40 | 0.150 |
Why?
|
Neuropsychological Tests | 2 | 2021 | 6993 | 0.150 |
Why?
|
Gene Frequency | 2 | 2023 | 3588 | 0.150 |
Why?
|
Lung | 1 | 2016 | 9856 | 0.150 |
Why?
|
Esotropia | 1 | 2018 | 91 | 0.150 |
Why?
|
Cardiac Myosins | 1 | 2017 | 117 | 0.150 |
Why?
|
Vascular Endothelial Growth Factor Receptor-3 | 1 | 2017 | 118 | 0.150 |
Why?
|
Milk, Human | 1 | 2021 | 490 | 0.150 |
Why?
|
Conscious Sedation | 1 | 2021 | 528 | 0.150 |
Why?
|
Multicenter Studies as Topic | 1 | 2022 | 1677 | 0.140 |
Why?
|
Boston | 2 | 2021 | 9313 | 0.140 |
Why?
|
Foramen Ovale | 1 | 2016 | 14 | 0.140 |
Why?
|
Brain | 2 | 2021 | 26385 | 0.140 |
Why?
|
RNA, Untranslated | 1 | 2020 | 453 | 0.140 |
Why?
|
Ductus Arteriosus | 1 | 2016 | 39 | 0.140 |
Why?
|
Calcium Signaling | 1 | 2021 | 721 | 0.140 |
Why?
|
CpG Islands | 1 | 2020 | 1172 | 0.140 |
Why?
|
Electron Transport | 1 | 2017 | 211 | 0.140 |
Why?
|
Myosin Heavy Chains | 1 | 2017 | 414 | 0.130 |
Why?
|
Software | 2 | 2020 | 4443 | 0.130 |
Why?
|
RNA | 2 | 2023 | 2749 | 0.130 |
Why?
|
Infant, Very Low Birth Weight | 1 | 2018 | 406 | 0.130 |
Why?
|
Hypotension | 1 | 2021 | 884 | 0.130 |
Why?
|
Abnormalities, Multiple | 1 | 2023 | 1416 | 0.130 |
Why?
|
Developmental Disabilities | 2 | 2021 | 1456 | 0.130 |
Why?
|
Analgesics, Opioid | 2 | 2021 | 3674 | 0.130 |
Why?
|
Cytomegalovirus Infections | 1 | 2022 | 820 | 0.130 |
Why?
|
Nuclear Proteins | 2 | 2022 | 5853 | 0.130 |
Why?
|
Genetic Variation | 2 | 2021 | 6544 | 0.130 |
Why?
|
Child, Preschool | 8 | 2021 | 41006 | 0.130 |
Why?
|
Male | 18 | 2023 | 350118 | 0.130 |
Why?
|
Organ Size | 1 | 2020 | 2252 | 0.130 |
Why?
|
Caspase 3 | 2 | 2007 | 758 | 0.120 |
Why?
|
Cyclin E | 1 | 2015 | 172 | 0.120 |
Why?
|
GTP-Binding Proteins | 1 | 2019 | 970 | 0.120 |
Why?
|
Adult | 16 | 2023 | 214055 | 0.120 |
Why?
|
Placenta | 1 | 2023 | 1698 | 0.120 |
Why?
|
Pancreas | 1 | 2020 | 1686 | 0.120 |
Why?
|
Pulmonary Circulation | 1 | 2016 | 739 | 0.110 |
Why?
|
Microfilament Proteins | 1 | 2019 | 1152 | 0.110 |
Why?
|
Mitochondrial Diseases | 1 | 2017 | 320 | 0.110 |
Why?
|
Gene Regulatory Networks | 1 | 2022 | 1708 | 0.110 |
Why?
|
Mammals | 1 | 2019 | 1143 | 0.110 |
Why?
|
Cyclin D1 | 1 | 2015 | 463 | 0.110 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2022 | 2540 | 0.110 |
Why?
|
Respiratory Insufficiency | 1 | 2021 | 1199 | 0.110 |
Why?
|
Consensus | 1 | 2022 | 2959 | 0.110 |
Why?
|
Neoplasms | 2 | 2021 | 21683 | 0.110 |
Why?
|
Protein Processing, Post-Translational | 1 | 2021 | 1990 | 0.110 |
Why?
|
Young Adult | 8 | 2023 | 56430 | 0.110 |
Why?
|
Proteomics | 2 | 2022 | 3638 | 0.110 |
Why?
|
Parturition | 1 | 2016 | 441 | 0.110 |
Why?
|
Mutation | 10 | 2024 | 29786 | 0.100 |
Why?
|
Transcription Factors | 3 | 2022 | 12208 | 0.100 |
Why?
|
Mice | 10 | 2022 | 81183 | 0.100 |
Why?
|
Mothers | 1 | 2022 | 2165 | 0.100 |
Why?
|
Time Factors | 3 | 2021 | 40075 | 0.100 |
Why?
|
Chromatin | 1 | 2023 | 2934 | 0.100 |
Why?
|
Premature Birth | 1 | 2023 | 1721 | 0.100 |
Why?
|
Gene Expression Regulation | 3 | 2021 | 12072 | 0.100 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2021 | 3760 | 0.090 |
Why?
|
Oncogene Proteins | 1 | 2015 | 749 | 0.090 |
Why?
|
Nitrosation | 2 | 2007 | 26 | 0.090 |
Why?
|
Epigenesis, Genetic | 2 | 2020 | 3647 | 0.090 |
Why?
|
Patient Admission | 1 | 2018 | 1380 | 0.090 |
Why?
|
Patient Care Team | 1 | 2021 | 2531 | 0.090 |
Why?
|
Cohort Studies | 4 | 2023 | 40561 | 0.090 |
Why?
|
Mitosis | 1 | 2015 | 1208 | 0.090 |
Why?
|
Referral and Consultation | 2 | 2023 | 3528 | 0.090 |
Why?
|
Cell Line | 2 | 2021 | 15997 | 0.090 |
Why?
|
Pilot Projects | 1 | 2022 | 8324 | 0.080 |
Why?
|
Models, Genetic | 1 | 2019 | 3494 | 0.080 |
Why?
|
Prospective Studies | 3 | 2023 | 53288 | 0.080 |
Why?
|
Mitochondria | 2 | 2022 | 3520 | 0.080 |
Why?
|
Autistic Disorder | 1 | 2017 | 1185 | 0.080 |
Why?
|
Cell Differentiation | 3 | 2021 | 11483 | 0.080 |
Why?
|
Animals | 11 | 2022 | 168757 | 0.080 |
Why?
|
Guideline Adherence | 1 | 2018 | 2266 | 0.080 |
Why?
|
Retrospective Studies | 3 | 2022 | 77449 | 0.080 |
Why?
|
Polymorphism, Single Nucleotide | 4 | 2020 | 15519 | 0.070 |
Why?
|
Genome, Human | 1 | 2020 | 4420 | 0.070 |
Why?
|
Actins | 1 | 2015 | 2121 | 0.070 |
Why?
|
Enzyme Precursors | 1 | 2007 | 176 | 0.070 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2019 | 2408 | 0.070 |
Why?
|
Organogenesis | 1 | 2008 | 222 | 0.070 |
Why?
|
NIH 3T3 Cells | 1 | 2008 | 677 | 0.070 |
Why?
|
DNA Methylation | 1 | 2020 | 4286 | 0.070 |
Why?
|
Apoptosis | 3 | 2015 | 9727 | 0.070 |
Why?
|
Survival | 1 | 2007 | 163 | 0.070 |
Why?
|
Cholesterol | 1 | 2015 | 2917 | 0.070 |
Why?
|
Thioredoxins | 1 | 2007 | 213 | 0.070 |
Why?
|
Nitrates | 1 | 2007 | 265 | 0.070 |
Why?
|
Chemistry, Pharmaceutical | 1 | 2006 | 281 | 0.070 |
Why?
|
Zebrafish Proteins | 2 | 2008 | 1005 | 0.070 |
Why?
|
Disease Management | 1 | 2016 | 2459 | 0.060 |
Why?
|
Cerebral Cortex | 1 | 2021 | 5708 | 0.060 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2009 | 687 | 0.060 |
Why?
|
Child Mortality | 1 | 2007 | 198 | 0.060 |
Why?
|
Stress, Psychological | 1 | 2019 | 4245 | 0.060 |
Why?
|
Body Mass Index | 1 | 2022 | 12720 | 0.060 |
Why?
|
Maternal Mortality | 1 | 2007 | 310 | 0.060 |
Why?
|
Magnetic Resonance Imaging | 2 | 2021 | 35421 | 0.060 |
Why?
|
Myocytes, Cardiac | 2 | 2024 | 1637 | 0.060 |
Why?
|
Cell Lineage | 2 | 2009 | 2504 | 0.060 |
Why?
|
Homozygote | 2 | 2017 | 1785 | 0.050 |
Why?
|
Blood Vessels | 1 | 2008 | 1125 | 0.050 |
Why?
|
Facies | 1 | 2023 | 197 | 0.050 |
Why?
|
Fimbriae, Bacterial | 1 | 2022 | 138 | 0.050 |
Why?
|
Infant Mortality | 1 | 2007 | 754 | 0.050 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2007 | 1157 | 0.050 |
Why?
|
Founder Effect | 1 | 2022 | 189 | 0.050 |
Why?
|
Repressor Proteins | 2 | 2023 | 3023 | 0.050 |
Why?
|
Cross-Sectional Studies | 1 | 2023 | 25043 | 0.050 |
Why?
|
Ear, External | 1 | 2022 | 161 | 0.050 |
Why?
|
Aged | 4 | 2021 | 163280 | 0.050 |
Why?
|
Neovascularization, Physiologic | 1 | 2008 | 1351 | 0.050 |
Why?
|
Aged, 80 and over | 3 | 2021 | 57776 | 0.050 |
Why?
|
Phenotype | 4 | 2023 | 16365 | 0.050 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2008 | 3617 | 0.050 |
Why?
|
Base Sequence | 3 | 2018 | 12797 | 0.050 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2024 | 794 | 0.050 |
Why?
|
Mice, Knockout | 1 | 2015 | 14557 | 0.040 |
Why?
|
Prognosis | 1 | 2020 | 29063 | 0.040 |
Why?
|
Obesity | 1 | 2022 | 12745 | 0.040 |
Why?
|
Odds Ratio | 3 | 2020 | 9849 | 0.040 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2020 | 323 | 0.040 |
Why?
|
T-Box Domain Proteins | 1 | 2022 | 471 | 0.040 |
Why?
|
Polyribosomes | 1 | 2019 | 110 | 0.040 |
Why?
|
Haploinsufficiency | 1 | 2021 | 328 | 0.040 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2020 | 373 | 0.040 |
Why?
|
Risk Factors | 2 | 2022 | 72290 | 0.040 |
Why?
|
Accommodation, Ocular | 1 | 2018 | 48 | 0.040 |
Why?
|
United States | 2 | 2023 | 69872 | 0.040 |
Why?
|
RNA Splicing | 1 | 2023 | 907 | 0.040 |
Why?
|
Acetylation | 1 | 2021 | 1085 | 0.040 |
Why?
|
Middle Aged | 6 | 2021 | 213383 | 0.040 |
Why?
|
Nitric Oxide | 1 | 2006 | 2132 | 0.040 |
Why?
|
Morbidity | 1 | 2023 | 1769 | 0.040 |
Why?
|
Reference Standards | 1 | 2021 | 1025 | 0.040 |
Why?
|
Mosaicism | 1 | 2020 | 441 | 0.040 |
Why?
|
INDEL Mutation | 1 | 2018 | 279 | 0.040 |
Why?
|
Denmark | 1 | 2019 | 738 | 0.040 |
Why?
|
Open Reading Frames | 1 | 2020 | 810 | 0.040 |
Why?
|
Failure to Thrive | 1 | 2017 | 136 | 0.040 |
Why?
|
Emigration and Immigration | 1 | 2019 | 404 | 0.040 |
Why?
|
Syndrome | 1 | 2023 | 3251 | 0.040 |
Why?
|
Follow-Up Studies | 1 | 2018 | 39050 | 0.030 |
Why?
|
Binding Sites | 2 | 2020 | 6114 | 0.030 |
Why?
|
Pituitary-Adrenal System | 1 | 2019 | 553 | 0.030 |
Why?
|
Corpus Callosum | 1 | 2021 | 737 | 0.030 |
Why?
|
Heart Ventricles | 1 | 2008 | 3821 | 0.030 |
Why?
|
Receptors, Immunologic | 1 | 2022 | 1423 | 0.030 |
Why?
|
Ribosomes | 1 | 2019 | 500 | 0.030 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2019 | 703 | 0.030 |
Why?
|
Water | 1 | 2021 | 1395 | 0.030 |
Why?
|
Point Mutation | 1 | 2020 | 1623 | 0.030 |
Why?
|
Uncertainty | 1 | 2019 | 734 | 0.030 |
Why?
|
Metabolome | 1 | 2021 | 895 | 0.030 |
Why?
|
Endothelial Cells | 2 | 2022 | 3479 | 0.030 |
Why?
|
Hospitalization | 2 | 2023 | 10262 | 0.030 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2021 | 1534 | 0.030 |
Why?
|
Documentation | 1 | 2019 | 871 | 0.030 |
Why?
|
Metabolic Diseases | 1 | 2019 | 658 | 0.030 |
Why?
|
Mood Disorders | 1 | 2019 | 1106 | 0.030 |
Why?
|
Epilepsy | 2 | 2019 | 3310 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2017 | 1730 | 0.030 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2019 | 1338 | 0.030 |
Why?
|
Transcription, Genetic | 2 | 2020 | 7722 | 0.030 |
Why?
|
Oxygen | 1 | 2023 | 4189 | 0.020 |
Why?
|
RNA-Binding Proteins | 1 | 2020 | 1903 | 0.020 |
Why?
|
Proteome | 1 | 2021 | 1799 | 0.020 |
Why?
|
Heterozygote | 1 | 2017 | 2804 | 0.020 |
Why?
|
Models, Animal | 1 | 2017 | 2171 | 0.020 |
Why?
|
ets-Domain Protein Elk-4 | 1 | 2009 | 5 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 2018 | 4740 | 0.020 |
Why?
|
Pedigree | 1 | 2017 | 4644 | 0.020 |
Why?
|
Up-Regulation | 1 | 2019 | 4217 | 0.020 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2019 | 2109 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2020 | 6538 | 0.020 |
Why?
|
Echocardiography | 1 | 2022 | 5102 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 2022 | 4462 | 0.020 |
Why?
|
Genome-Wide Association Study | 2 | 2018 | 12261 | 0.020 |
Why?
|
Signal Transduction | 2 | 2008 | 23403 | 0.020 |
Why?
|
Poverty | 1 | 2019 | 2660 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2022 | 12959 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2018 | 4803 | 0.020 |
Why?
|
Heart Transplantation | 1 | 2020 | 3110 | 0.020 |
Why?
|
Disease Progression | 1 | 2023 | 13284 | 0.020 |
Why?
|
Caspase 9 | 1 | 2006 | 188 | 0.020 |
Why?
|
Saccharomyces cerevisiae | 1 | 2017 | 2752 | 0.020 |
Why?
|
Biotin | 1 | 2006 | 254 | 0.020 |
Why?
|
Feedback, Physiological | 1 | 2008 | 479 | 0.020 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2008 | 707 | 0.020 |
Why?
|
Jurkat Cells | 1 | 2007 | 743 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2020 | 12354 | 0.020 |
Why?
|
Cyclic GMP | 1 | 2006 | 409 | 0.020 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2008 | 436 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2023 | 7181 | 0.020 |
Why?
|
Risk | 1 | 2017 | 9687 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2017 | 3597 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2021 | 19229 | 0.020 |
Why?
|
Embryo, Nonmammalian | 1 | 2008 | 895 | 0.020 |
Why?
|
Haiti | 1 | 2007 | 553 | 0.020 |
Why?
|
Gene Expression | 1 | 2017 | 7799 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2020 | 9438 | 0.020 |
Why?
|
Registries | 1 | 2019 | 8089 | 0.010 |
Why?
|
Substrate Specificity | 1 | 2007 | 1801 | 0.010 |
Why?
|
Prevalence | 1 | 2019 | 15226 | 0.010 |
Why?
|
Age Factors | 1 | 2019 | 18370 | 0.010 |
Why?
|
HeLa Cells | 1 | 2008 | 3128 | 0.010 |
Why?
|
Cysteine | 1 | 2006 | 874 | 0.010 |
Why?
|
Drug Design | 1 | 2006 | 1076 | 0.010 |
Why?
|
Incidence | 1 | 2019 | 20947 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2019 | 21827 | 0.010 |
Why?
|
Vascular Diseases | 1 | 2009 | 1161 | 0.010 |
Why?
|
Schizophrenia | 1 | 2019 | 6882 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2006 | 3701 | 0.010 |
Why?
|
Homeodomain Proteins | 1 | 2009 | 2421 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2008 | 3920 | 0.010 |
Why?
|
Kinetics | 1 | 2006 | 6473 | 0.010 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2008 | 2938 | 0.010 |
Why?
|
Risk Assessment | 1 | 2019 | 23338 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2008 | 3508 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2009 | 9734 | 0.010 |
Why?
|
Rural Population | 1 | 2007 | 2210 | 0.010 |
Why?
|
Myocardium | 1 | 2009 | 4776 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2008 | 18111 | 0.010 |
Why?
|
Peptides | 1 | 2006 | 4409 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2009 | 10481 | 0.010 |
Why?
|
Models, Biological | 1 | 2009 | 9583 | 0.010 |
Why?
|